期刊文献+

血清ICTP与TRACP 5b联合检测在乳腺癌骨转移诊断中的价值 被引量:1

Combined detection of serum ICTP and TRACP 5b for diagnosis of breast cancer bone metastasis
原文传递
导出
摘要 目的:探讨溶骨性骨代谢标志物血I型胶原交联羧基末端肽(ICTP)和血抗酒石酸酸性磷酸酶5b(TRACP 5b)的检测对诊断乳腺癌骨转移的价值。方法:用ELISA法测定78例乳腺癌患者及40例乳腺良性肿瘤患者血清ICTP和TRACP 5b水平,比较两者水平在骨转移、非骨转移乳腺癌患者及良性乳腺肿瘤患者中的差异及其相关性。结果:乳腺癌骨转移患者血清ICTP和TRACP 5b水平均明显高于无骨转移及乳腺良性肿瘤患者(均P<0.001),而后两者间无统计学差异(均P>0.05)。乳腺癌患者血清ICTP与TRACP 5b浓度表达呈正相关(r=0.63,P<0.01)。血清ICTP和TRACP诊断乳腺癌骨转移的敏感性、特异性和准确性分别为55.3%,92.5%,81.4%和84.2%,83.8%,83.9%,两者联合检测分别为94.7%,81.3%,85.6%。结论:血清ICTP和TRACP 5b对乳腺癌骨转移的诊断均有重要价值,两者联合检测有助于提高诊断的敏感性和准确性。 Objective: To evaluate the value of the combined detection of serum levels of bone turnover markers ICTP(pyridinoline crosslinked C-telopeptides of type I collagen) and TRACP 5b(tartrate-resistand acid phosphatase 5b) for diagnosis of breast cancer bone metastasis.Methods: e serum levels of ICTP and T CP 5b in 78 patients with breast cancer and 40 patients with benign breast tumors were measured by ELISA assay.e di erences in serum levels of the two markers amongbreast cancer patients with bone metastases,breast cancer patients without bone metastasis and benign breast tumor patients were compared,and the correlation between both levels was also analyzed.Results: he serum levels of both ICTP and TACP 5b in breast cancer patients with bone metastases were significantly higher than those in breast cancer patients without bone metastasis and benign breast tumor patients(all P0.001),while both levels between the latter two showed no significant differences(both P0.05).here was a positive correlation between serum ICTP and TACP 5b levels in breast cancer patients(r=0.63,P0.01).For diagnosis of breast cancer bone metastasis,the sensitivity,speciicity and accuracy of serum ICTP detection were 55.3%,92.5% and 81.4%,those of serum TACP 5b detection were 84.2%,83.8%,83.9%,and the combined detection rates were 94.7%,81.3% and 85.6%,respectively.Conclusion: Both serum ICTP and TRACP 5b levels have important value for diagnosis of breast cancer bone metastasis,and their combined detection can improve the diagnostic sensitivity and accuracy.
作者 张辉 唐中华
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2013年第5期555-559,共5页 China Journal of General Surgery
关键词 乳腺肿瘤 肿瘤转移 诊断 I型胶原交联羧基末端肽 抗酒石酸酸性磷酸酶5B Breast Neoplasms Neoplasm Metastasis/diag Pyridinoline Crosslinked C-Telopeptides of Type I Collagen Tartrate-Resistand Acid Phosphatase 5b
  • 相关文献

参考文献17

  • 1胡旭民,李玉斐,张常华.肿瘤骨转移机制研究的新进展[J].中国普通外科杂志,2011,20(2):194-199. 被引量:14
  • 2王江涛,王捷,欧陕兴,乔国庆,唐咸国,李小荣,蔡俊杰.乳腺癌裸鼠骨转移模型的建立及评估[J].中国普通外科杂志,2009,18(11):1156-1160. 被引量:4
  • 3Garnero P, Ferreras M, Karsdal MA, et al. The lype 1 collagen fragments ICTP and CTX reveal distinet enzymatic pathways of bone collagen degradation[J]. J Bone Miner Res, 2003, 18(5):859- 867.
  • 4Koizumi M, Ogata E. Bone metabolic markers as gauges of metastasis to bone: a review[J}. Ann Nucl Med, 2002, 16(3):161- 168.
  • 5Koizumi M, Yamada Y, Takiglwhi T, et al. Bone metabolic markers in hone melaslases[J]. J Cancer Res Clin Oneol, 1995, 121(9- 10):542-548.
  • 6Ulrich U, Rhiem K, Scbmolling J, et al. Cross-linked type I collagen C- and N-telopeptides in women with bone metastases from breast cancer [J]. Arch Gynecol Obstet, 2001, 264(4):186-190.
  • 7Voorzanger-Rousselot N, Juillet F, Mareau E, et al. Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation[J]. Br J Cancer, 2006, 95(4):506-514.
  • 8Wada N, Fujisaki M, lshii S, ctal. Evaluation of bone metabolic markers in breast cancer with bone metastasis[J]. Breast Cancer, 2001, 8(2):131-137.
  • 9Halleen JM. Tarlrate-resistanl acid phosphatasc 5B is a specificand sensitive marker of bone resorption[J]. Antieancer Res, 2003, 23(2A): 1027-1029.
  • 10Chao TY, Yu JC, Ku CH, et al. Tartrate-resistant acid phosphatase 5b is a useful senlm marker for extensive bone metastasis in breast cancer patients[J]. Clin Cancer Res, 2005, 11(2 Pt 1):544-550.

二级参考文献51

  • 1张铭.乳腺癌患者血清CA15-3的检测及临床意义[J].医学研究生学报,1999,12(1):11-13. 被引量:2
  • 2Gregory R, Mundy. Metastasis to bone : causes, consequences and therapeutic opportunities [ J ]. Nat Rev Cancer, 2002, 2(8) :584 -593.
  • 3Tarik F, Massoud, Sanjiv S, et al. Molecular imaging in living subjects: seeing fundamental biological processes in a new light [J]. Genes Dev, 2003, 17 (5) :545 -580.
  • 4Bauerle T, Peterschmitt J, Hilbig H, et al. Treatment of bone metastasis induced by MDA-MB-231 breast cancer cells with an antibody against bone sialoprotein [ J ] . lnt J Oncol , 2006, 28(3) :573 -583.
  • 5Lyons SK, Lim E, Clermont AO, et al. Noninvasive biolumineseence imaging of normal and spontaneously transformed prostate tissue in mice [ J]. Cancer Res, 2006, 66(9) : 4701 -4707.
  • 6Wetterwald A, Vander PG, Que I, et al. Optical imaging of cancer metastasis to bone marrow : a mouse model of minimal residual disease [ J]. Am J Pathol, 2002, 160 (3) : 1143 -1153.
  • 7Chatziioannou AF. Instrumentation for molecular imaging in Preclinical Research: Micro-PET and Micro-SPECT [ J ]. Proc Am Thorac Soc,2005 , 2(6) : 533 -536.
  • 8Strube A, Hoffmann J, Stepina E, et al. Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption [J]. Clin Cancer Res,2009, 15(11) :3751 -3759.
  • 9孟宇宏,虞积耀,陆应麟.凝血酶与肿瘤转移[J].中国实验血液学杂志,2007,15(3):671-674. 被引量:11
  • 10Dougall WC, Chaisson M. The RANK/RANKL/OPG triad in cancer-induced bone diseases [J].Cancer Metastasis Rev, 2006, 25(4) : 541 -549.

共引文献19

同被引文献11

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部